Human Amyloid Imaging (HAI) Meeting

摘要： 该提案请求对由基思A. 约翰逊，医学博士，威廉J. Jagust，医学博士，威廉E. Klunk，医学博士，博士和切斯特马西斯，医学博士，将举行 2018年1月17日至19日在佛罗里达的迈阿密举行。会议将以一种独特的简短组合为特色， 研究报告，口头报告，主题演讲，公开讨论，简短的教学方法 讲座，海报会议和网络广播。这些演讲将经过同行评审，并将重点放在 关于阿尔茨海默病生物学和生物标志物研究的核心争议。目的是 延续了前11次HAI会议的传统，汇集了一批跨学科的密切合作者， 400名小组成员和演讲者将提供神经病理学，神经化学， 心理学、神经学、分子成像、临床试验和生物标志物研究。会议将 作为一个高度互动的平台，为学术界和工业界的科学家打算讨论切割 人类对淀粉样蛋白β和/或其他与阿尔茨海默氏症有关的生物标志物成像的边缘研究 相关疾病。我们还将继续传统，只展示最近的重要作品， 在会议开始前不到两个月， 会议

ABSTRACT: This proposal requests support for the 12th Human Amyloid Imaging conference organized by Keith A. Johnson, MD, William J. Jagust, MD, William E. Klunk, MD, PhD, and Chester Mathis, MD, to be held in Miami, Florida, January 17-19, 2018. The meeting will feature a unique combination of brief research reports, oral presentations, keynote lectures, open discussion, brief didactic methods lectures, a poster session, and a webcast. These presentations will be peer-reviewed and will focus on the core controversies in Alzheimer's disease biology and biomarker research. The aim is to continue the tradition of the first 11 HAI meetings, bringing together a cross-disciplinary mass of close to 400 panelists and presenters who will provide perspectives from neuropathology, neurochemistry, psychology, neurology, molecular imaging, clinical trials and biomarker research. The meeting will serve as a highly interactive platform for academic and industry scientists intent on discussing cutting edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer's related disease. We will also continue the tradition of featuring only the most recent, important work in the field by again conducting peer–review of submitted material less than two months prior to the meeting.